140 related articles for article (PubMed ID: 21809636)
1. [Effect of alendronate on bone tissue status of senescence-accelerated OXYS rats].
Muraleva NA; Sadovoĭ MA; Kolosova NG
Adv Gerontol; 2011; 24(1):143-6. PubMed ID: 21809636
[TBL] [Abstract][Full Text] [Related]
2. Prevention of glucocorticoid induced osteoporosis with alendronate or alfacalcidol: relations of change in bone mineral density, bone markers, and calcium homeostasis.
Jacobs JW; de Nijs RN; Lems WF; Geusens PP; Laan RF; Huisman AM; Algra A; Buskens E; Hofbauer LC; Oostveen AC; Bruyn GA; Dijkmans BA; Bijlsma JW
J Rheumatol; 2007 May; 34(5):1051-7. PubMed ID: 17407214
[TBL] [Abstract][Full Text] [Related]
3. [Development of osteoporosis in prematurely aging OXYS rats].
Muraleva NA; Sadovoĭ MA; Kolosova NG
Adv Gerontol; 2010; 23(2):233-42. PubMed ID: 21033378
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of glucosamine alendronate alone & in combination with dihydroquercetin for treatment of osteoporosis in animal model.
Muraleva NA; Ofitserov EN; Tikhonov VP; Kolosova NG
Indian J Med Res; 2012; 135(2):221-7. PubMed ID: 22446865
[TBL] [Abstract][Full Text] [Related]
5. Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism.
Rossini M; Gatti D; Isaia G; Sartori L; Braga V; Adami S
J Bone Miner Res; 2001 Jan; 16(1):113-9. PubMed ID: 11149474
[TBL] [Abstract][Full Text] [Related]
6. Effects of odanacatib on BMD and safety in the treatment of osteoporosis in postmenopausal women previously treated with alendronate: a randomized placebo-controlled trial.
Bonnick S; De Villiers T; Odio A; Palacios S; Chapurlat R; DaSilva C; Scott BB; Le Bailly De Tilleghem C; Leung AT; Gurner D
J Clin Endocrinol Metab; 2013 Dec; 98(12):4727-35. PubMed ID: 24064689
[TBL] [Abstract][Full Text] [Related]
7. Alendronate administration and skeletal response during chronic alcohol intake in the adolescent male rat.
Wezeman FH; Emanuele MA; Moskal SF; Steiner J; Lapaglia N
J Bone Miner Res; 2000 Oct; 15(10):2033-41. PubMed ID: 11028458
[TBL] [Abstract][Full Text] [Related]
8. Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women.
Murphy MG; Weiss S; McClung M; Schnitzer T; Cerchio K; Connor J; Krupa D; Gertz BJ;
J Clin Endocrinol Metab; 2001 Mar; 86(3):1116-25. PubMed ID: 11238495
[TBL] [Abstract][Full Text] [Related]
9. Alendronate therapy in cyclosporine-induced alveolar bone loss in rats.
Spolidorio LC; Marcantonio E; Spolidorio DM; Nassar CA; Nassar PO; Marcantonio RA; Rossa C
J Periodontal Res; 2007 Oct; 42(5):466-73. PubMed ID: 17760825
[TBL] [Abstract][Full Text] [Related]
10. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
[TBL] [Abstract][Full Text] [Related]
11. The effects of ronacaleret, a calcium-sensing receptor antagonist, on bone mineral density and biochemical markers of bone turnover in postmenopausal women with low bone mineral density.
Fitzpatrick LA; Dabrowski CE; Cicconetti G; Gordon DN; Papapoulos S; Bone HG; Bilezikian JP
J Clin Endocrinol Metab; 2011 Aug; 96(8):2441-9. PubMed ID: 21593114
[TBL] [Abstract][Full Text] [Related]
12. [Bone matrix glycosaminoglycans and osteoporosis development in early aging OXYS rats].
Ershov KI; Rusova TV; Falameeva OV; Sadovoĭ MA; Aĭzman RI; Kolosova NG
Adv Gerontol; 2009; 22(2):285-91. PubMed ID: 19947392
[TBL] [Abstract][Full Text] [Related]
13. Exercise prevented the lansoprazole-induced reduction of anti-osteoporotic efficacy of alendronate in androgen deficiency rats.
Cegieła U; Pytlik M; Folwarczna J; Miozga R; Piskorz S; Nowak D
Acta Pol Pharm; 2014; 71(3):485-95. PubMed ID: 25265829
[TBL] [Abstract][Full Text] [Related]
14. Synergistic antiosteoporotic effect of Lepidium sativum and alendronate in glucocorticoid-induced osteoporosis in Wistar rats.
Elshal MF; Almalki AL; Hussein HK; Khan JA
Afr J Tradit Complement Altern Med; 2013; 10(5):267-73. PubMed ID: 24311835
[TBL] [Abstract][Full Text] [Related]
15. The effect of oestrogen and alendronate therapies on postmenopausal bone loss around osseointegrated titanium implants.
Giro G; Coelho PG; Pereira RM; Jorgetti V; Marcantonio E; Orrico SR
Clin Oral Implants Res; 2011 Mar; 22(3):259-64. PubMed ID: 20946210
[TBL] [Abstract][Full Text] [Related]
16. A Comparative Study of Intravenous Injection Form and Oral Jelly Form of Alendronate Sodium Hydrate for Bone Mineral Disorder after Gastrectomy.
Kunisaki C; Tanaka Y; Kosaka T; Miyamoto H; Sato S; Suematsu H; Yukawa N; Sato K; Izumisawa Y; Akiyama H; Taguri M; Yamanaka T; Endo I
Digestion; 2017; 95(2):162-171. PubMed ID: 28214864
[TBL] [Abstract][Full Text] [Related]
17. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial.
Greenspan SL; Parker RA; Ferguson L; Rosen HN; Maitland-Ramsey L; Karpf DB
J Bone Miner Res; 1998 Sep; 13(9):1431-8. PubMed ID: 9738515
[TBL] [Abstract][Full Text] [Related]
18. A synergistic bone sparing effect of curcumin and alendronate in ovariectomized rat.
Cho DC; Kim KT; Jeon Y; Sung JK
Acta Neurochir (Wien); 2012 Dec; 154(12):2215-23. PubMed ID: 23053289
[TBL] [Abstract][Full Text] [Related]
19. Effect of a short-term treatment with alendronate on bone density and bone markers in patients with central diabetes insipidus.
Pivonello R; Faggiano A; Di Somma C; Klain M; Filippella M; Salvatore M; Lombardi G; Colao A
J Clin Endocrinol Metab; 1999 Jul; 84(7):2349-52. PubMed ID: 10404801
[TBL] [Abstract][Full Text] [Related]
20. Effect of estrogen replacement plus low-dose alendronate treatment on bone density in surgically postmenopausal women with osteoporosis.
Palomba S; Orio F; Colao A; di Carlo C; Sena T; Lombardi G; Zullo F; Mastrantonio P
J Clin Endocrinol Metab; 2002 Apr; 87(4):1502-8. PubMed ID: 11932272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
